Vitamin D Deficiency in Patients with Diabetic Peripheral Neuropathy by Khan, Hameedullah et al.
                            291 JIMDC  2018  291 
Open Access 
Ful l  Length  Art ic l e  
 
 Vitamin D Deficiency in Patients with Diabetic Peripheral 
Neuropathy 
 
Hameedullah Khan1, Ihsanullah Rajar2 , Abdul Rauf Memon3 , Nadeem Naeem4  
1 Assistant professor, Neuro surgery Department of Indus Medical College Tando Muhammad khan 
2 Senior Registrar, Department of Medicine, LUMHS, Nawabshah 
3 Senior Registrar, Department of Neurosurgery, LUMHS, Nawabshah 
4 Fellow, Diabetes, Endocrinology and Metabolism, Baqai Institute of Diabetology and Endocrinology Karachi 
A B S T R A C T  
Objective: To determine the frequency of vitamin D deficiency in patients presenting with diabetic peripheral neuropathy 
Patients and Methods: This cross sectional study was carried out in Department of Medicine and Neurology Indus 
Medical College, Tando Muhammad khan. from March 2017 to August 2017. Total 74 cases of Diabetes Mellitus 
presenting with peripheral diabetic neuropathy were selected for the study. Evolution of degree of Neuropathy was 
based on TCSS score as: {no neuropathy: ≤5, severe: ≥12, moderate: 9-11 and mild: 6-8}. Vitamin D level was 
categorized as (deficiency (0-20 ng/ml), insufficiency (21-30 ng/ml) sufficiency (>30 ng/ml), excess (>50 ng/ml) and 
toxicity (>100 ng/ml). All the data was entered in SPSS. 
Results: Total 74 patients with diabetic neuropathy were studied. Vast majority of patients 36(48.6%) were found in age 
group 51-60 years, Majority were males 45(60.8%). Most of the cases 35(47.3%) were with 1-3 years duration of 
neuropathy. Majority of patients 42(56.8%) were found with Mild peripheral neuropathy. Vitamin-D deficiency was 
present in 2(43.2%) cases and insufficiency was observed in 27(36.5%) cases. No significant association was found 
between vitamin D deficiency and severity of neuropathy. 
Conclusion:  Vitamin D deficiency was found (43.2%) in patients of diabetic peripheral neuropathy. Vitamin screening 
and intake of supplement is necessary, will help to decrease the complication of peripheral neuropathy in Diabetic cases. 
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I n t r o d u c t i o n  
 
Diabetes Mellitus Type 2 is a chronic metabolic syndrome 
characterized by abnormal blood glucose levels. About 
170 million people are affected with type 2 diabetes 
globally and the figures will increase to 370 million in 2030 
and 642 million in 2040.1,2 As per a Pakistani survey, 
incidence of currently diagnosed diabetes was 6.8% in 
females and 5.1% in males.3 Neuropathy is a commonest 
complication of diabetes mellitus and diabetes is the 
commonest factor of neuropathy in the United States, 
affecting around 50% of cases with Diabetes Mellitus. 
Symptoms generally involve weakness, pain, tingling, and 
numbness.4,5 Diabetic peripheral neuropathy is a frequent 
problem that affects these patients and is a key factor of 
elevated mortality as well as morbidity.6 Diabetic 
neuropathy is much challenging problem of diabetes, 
correlated with vast economic burden. It is reported to  
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Table 1: Demographic characteristics of patients 
(n=74) 
Basic characteristic Frequency Percentage 
Age groups (years)   
40 -50 27 36.5 
51-60 36 48.6 
>60 11 14.9 
Total 74 100.0 
Gender   
Female 29 39.2 
Male 45 60.8 
Total 74 100.0 
Duration of neuropathy 
(years) 
  
1-3  35 47.3 
4-5  24 32.4 
>5  15 20.3 
Total 74 100.0 
Peripheral neuropathy   
Mild 42 56.8 
Moderate 24 32.4 
Severe 8 10.8 
Total 74 100.0 
 
have an incidence of 39.6% within Karachi.7 It is essential 
to explain the potential risk factors for Diabetic peripheral 
neuropathy. As widely accepted, Diabetic peripheral 
neuropathy is raised with age and duration of diabetes. 
Current studies suggest that level of vitamin D contributes 
tremendously in influencing the generation as well as 
progression of diabetes mellitus in addition to 
complications related to it.8 Vitamin D is a vital fat-soluble 
vitamin, which is strongly associated with human health. 
Deficiency of Vitamin D can lead to several health 
complications for example distinguished osteoporosis 
during adulthood.9 
Numerous articles reported that vitamin D can possibly 
contribute its therapeutic role remarkably through 
immuno-modulatory mechanism. In addition, Vitamin D 
contributes significantly in preserving pancreatic β-cell 
functions by affecting several channels. Several studies 
have highlighted the potential relationship of diabetic 
peripheral neuropathy and deﬁciency of vitamin D.10-13 In 
the meantime, Therefore, deﬁciency of vitamin D can lead 
to the diabetes risk and its complications involving 
neuropathy, however because of the study design  
Table 2: Levels of vitamin D in studied population 
(n=74) 
Presentation Frequency (%) 
Levels of vitamin D (ng/ml)  
Deficiency (0-20) 32(43.2) 
Insufficiency (21-30) 27(36.5) 
Sufficiency (>30) 12(16.2) 
Excess  (>50) 03(04.1) 
 
difference, small sample size, regions and population of 
studies, there is yet no evident conclusion regarding the 
relationship amid diabetic peripheral neuropathy and 
vitamin D within diabetic cases. Currently in a study 
carried out, meta-analysis and systematic review to 
discover the effect of vitamin D levels in the diabetic 
peripheral neuropathy development within Type II diabetic 
mellitus, concluded that deficiency of vitamin D are 
1.22 folds to be influenced by DPN contrasted to normal 
vitamin D levels within Asian and suggested more 
research on this event.14 Therefore this study has been 
planned to evaluate the deficiency of vitamin D in diabetic 
peripheral neuropathy patients in our population. 
P a t i e n t s  a n d  M e t h o d s  
This cross sectional study was carried out in Department 
of Medicine and Neurology at Indus Medical College 
Tando Muhammad khan. Study duration was 6 months 
from March 2017 to August 2017. Total 74 cases of 
diabetes mellitus presenting with peripheral diabetic 
neuropathy were selected for the study. Sample size was 
calculated by raosoft software by taking proportion of 
diabetic peripheral neuropathy 36.6% with 10% margin of 
error and 95% confidence level.21 
Neuropathy degrees were based on Toronto Clinical 
Scoring System (TCSS) score applied within an earlier 
study as, no neuropathy: ≤5, mild:6-8, moderate: 9-11, 
severe: ≥12.15 Complete medical history including 
duration of diabetes, duration of neuropathy and clinical 
examination were carried out.  Patients with history of 
smoking, alcohol, obesity, anemia and uncontrolled 
hypertension were excluded. Total 5cc intravenous blood 
sample was taken to analyze vitamin D levels. Vitamin D 
level was categorized as, Deficiency: 0-20 ng/ml, 
Insufficiency: 21-30 ng/ml, Sufficiency: >30 ng/ml, 
Excess: >50 ng/ml and Toxicity: >100 ng/ml. All the data  
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Table 3: Degree of peripheral neuropathy according to Vitamin D levels 
 
Vitamin D level (ng/ml) 
 Neuropathy 
Mild n(%) Moderate n(%) Severe n(%) Total p-value 
Deficiency (0-20) 17(53) 12(38) 03(09) 32  
 
0.507 
Insufficiency (21-30) 13(48) 10(37) 04(15) 27 
Sufficiency (>30) 09(75) 02(17) 01(08) 12 
Excess (>50) 03(100) 00(00) 00(00) 03 
 
were entered on predesigned proforma. SPSS was used 
for data analysis, frequency and percentage were 
computed for qualitative variable. Mean and standard 
deviation were computed for quantitative variable. Chi-
square test was applied to assess the association of 
vitamin D level with severity of neuropathy. P-value less 
than 0.05 was taken as statistically significant.  
R e s u l t s  
Total 74 patients with diabetic neuropathy were studied. 
Mean age of patients was 52.8 + 5.44 years. Majority of 
patients (48.6%) were found in age group 51-60 years. 
Gender wise distribution showed that males (60.8%) were 
in majority. Out of total 74, most patients (47.3%) 
presented with in 1-3 years of duration of neuropathy 
followed by 4-5 years (32.4%). Majority of patients 
(56.8%) were found to have mild peripheral neuropathy 
(Table 1). Out of overall 74 patients, Vitamin-D deficiency 
was found in 43.2%. Excess levels of vitamin D were 
present only in 4.1% (Table 2). Degree of peripheral 
neuropathy was insignificantly associated with vitamin D 
levels. Out of 32 patients suffering from vitamin D 
deficiency, 53% presented with mild neuropathy. In 
vitamin D insufficiency group, 48% had mild neuropathy. 
In vitamin D sufficiency proportion of mild neuropathy was 
75% (Table 3). 
D i s c u s s i o n  
In this study there is high frequency of vitamin D 
deficiency in diabetic patients. Peripheral neuropathy 
findings of our study underline the importance of 
screening for vitamin D deﬁciency in diabetic patients 
because vitamin D contributes significantly in diminishing 
the risk of several chronic disorders, like cancers, 
infections and cardiovascular diseases.15 This is  
 
particularly pertinent for diabetic patients who are at 
increased risk for acquiring these conditions as compared 
to the general population and therefore can possibly 
advantage from increased levels of vitamin D.16-18   There 
are both in vivo and in vitro evidence of Vitamin-D for 
being a neurotrophic substance and that it modulates 
neuromuscular functions as well as differentiation and 
neuronal growth. Peripheral neuropathy is a distressing 
and frequently a painful condition. Autoimmune disorders, 
infections, alcoholism, diabetes or trauma are potential 
cause. Peripheral neuropathy can cause infection or 
numbness in affected limb. Adequate Vitamin-D can 
assist in keeping the nervous system strong, and can 
possibly contribute in diminishing the peripheral 
neuropathy symptoms. In our study, out of 74, most of the 
cases 35(47.3%) were with 1-3 years of duration of 
neuropathy, 24 cases (32.4%) with 4-5 years and just 15 
cases (20.3%) were found with >5 years of duration of 
neuropathy. Greater part of patients 42(56.8%) were 
found with mild peripheral neuropathy, followed by 
moderate and sever, 24(32.4%) & 8(10.8%), respectively.  
In comparison to this, study conducted by Sheikh A et al 
17 reported that a substantial proportion of Diabetic 
patients in Karachi are deficit in vitamin D.  
This can possibly explain a signiﬁcant relationship 
between the peripheral diabetic neuropathy severity and 
vitamin D levels, have been reported. In our study, out of 
total cases of diabetic peripheral neuropathy, vitamin D 
deficiency was prevalent as 32(43.2%).  In comparison to 
our study, Diaz VA et al 19 reported in their study that, 
30.7% of diabetic adults had nephropathy, 48.9% were 
deﬁcit in vitamin D and 36.6% had insufﬁciency of vitamin 
D. One more study of Soderstrom LH et al 11 exhibited 
that insufficiency of Vitamin D was correlated with 
symptoms of self-stated peripheral neuropathy. 50% 
reported numbness (paresthesia) or pain within their feet 
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or hands; 37% reported tingling or pain within feet or 
hands; and 38% reported loss of feeling or numbness in 
feet or hands. Another study conducted by Shehab D et al 
also documented that deficiency of Vitamin D is an 
independent risk factor for diabetic peripheral 
neuropathy.18 
C o n c l u s i o n  
Vitamin D deficiency was seen in 43.3% in diabetic 
peripheral neuropathy cases, Vitamin screening and 
supplementation will help to decrease the complication of 
peripheral neuropathy in diabetic cases. 
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